首页|导管溶栓联合髂静脉球囊扩张对急性下肢深静脉血栓合并Cockett综合征并发症及凝血功能的影响

导管溶栓联合髂静脉球囊扩张对急性下肢深静脉血栓合并Cockett综合征并发症及凝血功能的影响

扫码查看
目的 分析导管溶栓联合髂静脉球囊扩张对急性下肢深静脉血栓(DVT)合并Cock-ett综合征病人疗效、并发症及凝血功能的影响.方法 2018年3月~2022年9月收治的急性DVT合并Cockett综合征病人102例,按治疗方法分为两组,研究组53例,采用导管溶栓联合髂静脉球囊扩张治疗;对照组49例,采用导管溶栓治疗.两组病人术后均随访1年.比较两组病人血栓清除情况、患肢消肿情况、下肢血流动力学、凝血功能、外周血炎症因子、并发症及血栓复发情况.结果 研究组血栓清除分级优于对照组,差异有统计学意义(P<0.05).对照组术前、术后1年患侧与健侧膝上腿围周径差分别为(8.02±1.41)cm、(2.89±0.32)cm,研究组分别为(8.19±1.38)cm、(2.57±0.29)cm,对照组术前、术后1年患侧与健侧膝下腿围周径差分别为(6.84±1.18)cm、(2.13±0.38)cm,研究组分别为(6.63±1.09)cm、(1.76±0.32)cm,差异有统计学意义(P<0.05),研究组术后1年更低(P<0.05).对照组术前、术后3天股静脉平均血流速度分别为(24.75±4.03)cm/s、(28.82±4.29)cm/s,研究组分别为(24.02±3.86)cm/s、(30.94±4.37)cm/s,对照组术前、术后3天股静脉血流量分别为(13.02±2.12)ml/s、(15.05±2.29)ml/s,研究组分别为(13.36±2.09)ml/s、(16.26±2.34)ml/s,差异有统计学意义(P<0.05),研究组术后3天更高(P<0.05).对照组术前、术后3天凝血酶原时间分别为(22.93±2.04)s、(18.13±1.34)s,研究组分别为(23.24±1.99)s、(17.29±1.21)s,对照组术前、术后3天凝血酶时间分别为(24.86±2.31)s、(21.04±1.75)s,观察组分别为(24.13±2.16)s、(19.89±1.53)s,对照组术前、术后 3 天活化部分凝血活酶时间分别为(59.21±3.92)s、(49.13±3.02)s,观察组分别为(60.17±3.85)s、(47.09±2.98)s,差异有统计学意义(P<0.05),研究组术后3天更低(P<0.05).研究组术前肿瘤坏死因子(TNF)-α、血小板活化因子(PAF)、血栓素B2(TXB2)分别为(31.91±4.89)ng/L、(14.59±2.36)pg/ml、(213.12±30.98)pg/ml,术后 3 天分别为(36.24±4.29)ng/L、(16.12±2.59)pg/ml、(239.86±32.85)pg/ml,差异有统计学意义(P<0.05),研究组术后3天TNF-α、PAF、TXB2更高(P<0.05).两组总并发症发生率比较差异无统计学意义(P>0.05).研究组血栓复发率低于对照组(3.77%比16.33%,P<0.05).结论 导管溶栓联合髂静脉球囊扩张治疗急性DVT合并Cockett综合征可增强血栓清除效果,并改善患肢肿胀情况及下肢血流动力学及凝血功能,降低血栓复发风险,安全可靠,但该治疗方案可介导炎症反应发生,术后应积极实施合理抗炎治疗.
Effect of balloon dilation combined with iliac vein balloon dilatation on complications and coagulation function of acute deep venous thrombosis of lower limbs complicated with Cockett syndrome
Objective To analyze the efficacy and effects of balloon dilation combined with iliac vein balloon dilatation on complications and coagulation function of acute deep venous thrombosis of lower limbs(DVT)complicated with Cockett syndrome.Methods Data of 102 patients with acute DVT combined with Cockett syndrome admitted to the hospital from March 2018 to September 2022 were retrospectively analyzed,including 53 patients treated with catheter thrombolytic balloon dilation of iliac vein(recorded as the study group)and 49 patients treated with catheter thrombolytic therapy(recorded as the control group).Both groups were followed up for 1 year.Thrombosis clearance,edema reduction of affected limb,lower limb hemodynamics,coagulation function,peripheral blood inflammatory factors,complications and thrombosis recurrence were compared between the two groups.Results The thrombus removal grade of the study group was better than that of the control group(P<0.05).Before and 1 year after surgery,In the control group,the leg circumference diameter difference above the knee between the affected side and the healthy side was(8.02±1.41)cm and(2.89±0.32)cm,respectively.In the study group,the data were(8.19±1.38)cm and(2.57±0.29)cm,respectively.Before and 1 year after surgery,in the control group,the leg circumference diameter difference below the knee between the affected side and the healthy side was(6.84±1.18)cm and(2.13±0.38)cm,respectively.In the study group,the data were(6.63±1.09)cm and(1.76±0.32)cm,respectively.The difference was statistically significant(P<0.05),and the study group was lower 1 year after surgery(P<0.05).The average blood flow velocity of femoral vein in control group was(24.75±4.03)cm/s and(28.82±4.29)cm/s before and 3 days after surgery,respectively.In the study group,the data were(24.02±3.86)cm/s and(30.94±4.37)cm/s,respectively.The femoral vein blood flow before and 3 days after surgery in the control group was(13.02±2.12)ml/s and(15.05±2.29)ml/s,respectively,while that in the study group was(13.36±2.09)ml/s and(16.26±2.34)ml/s,with statistical significance(P<0.05).The study group was higher 3 days after surgery(P<0.05).The prothrombin time before and 3 days after operation were(22.93±2.04)s and(18.13±1.34)s in the control group,and(23.24±1.99)s and(17.29±1.21)s in the study group,respectively.The thrombin time before and 3 days after operation were(24.86±2.31)s and(21.04±1.75)s in the control group,and(24.13±2.16)s and(19.89±1.53)s in the observation group,respectively.The activated partial thromboplastin time before and 3 days after surgery was(59.21±3.92)s and(49.13±3.02)s in control group,and(60.17±3.85)s and(47.09±2.98)s in observation group,respectively,and the difference was statistically significant(P<0.05).It was lower 3 days after surgery in study group(P<0.05).In the study group,preoperative tumor necrosis factor(TNF)-α,platelet activating factor(PAF)and thromboxen B2(TXB2)were(31.91±4.89)ng/L,(14.59±2.36)pg/ml,and(213.12±30.98)pg/ml,respectively.Three days after surgery,the levels were(36.24±4.29)ng/L,(16.12±2.59)pg/ml,and(239.86±32.85)pg/ml,respectively,with statistical significance(P<0.05).TNF-α,PAF and TXB2 were higher in the study group 3 days after surgery(P<0.05).There was no significant difference in the incidence of total complications between the two groups(P>0.05).The recurrence rate of thrombosis in study group was lower than that in control group(3.77%vs 16.33%,P<0.05).Conclusion Catheter thrombolytic balloon dilation of iliac vein for acute DVT complicated with Cockett syndrome can enhance the thrombolysis effect,improve the swelling of the affected limb,lower limb hemodynamics and coagulation function,and reduce the risk of thrombosis recurrence,which is safe and reliable.However,this treatment plan can mediate the occurrence of inflammation,and reasonable anti-inflammatory therapy should be actively implemented after surgery.

catheter thrombolysisiliac vein balloon dilatationacute deep venous thrombosis of lower extremityCockett syndromecurative effectsecurity

梁学刚、王祥金、张全刚

展开 >

065000 河北省廊坊市人民医院介入血管外科

导管溶栓 髂静脉球囊扩张 急性下肢深静脉血栓 Cockett综合征 疗效 安全性

2024

临床外科杂志
中华医学会湖北分会

临床外科杂志

CSTPCD
影响因子:0.716
ISSN:1005-6483
年,卷(期):2024.32(9)